{
    "success": true,
    "data": {
        "ucits": true,
        "type": "ETF",
        "leverage": false,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "synthetic",
        "complex_factors": [
            "Swaps",
            "Counterparty Risk",
            "Collateral Risk",
            "Synthetic Replication"
        ],
        "classification": "complex",
        "supporting_data": "The fund's objective is to reflect the performance of the IBOXX u20ac GERMANY COVEREDu00ae Index through synthetic replication. This involves entering into financial contracts (derivatives) with one or more swap counterparties. The document explicitly states that the fund does not invest directly in the components of the index and its returns are dependent on the performance of the bonds and/or cash deposits and the performance of the derivatives used. A key risk highlighted is 'COUNTERPARTY RISK: The fund will enter into a derivative with one or more counterparties. If any of the counterparties fails to make payment (for example, it becomes insolvent) this may result in your investment suffering a loss.' This use of swaps and the associated counterparty and collateral risks, as well as the reliance on synthetic replication, are primary drivers for classifying this ETF as complex under MiFID II. The presence of derivatives integral to the investment strategy makes it difficult for a retail investor with basic knowledge to understand the structure and risks involved, particularly counterparty risk and collateral management, which are not easily grasped concepts. According to MiFID II guidelines, instruments that use derivatives to replicate an index's performance are generally classified as complex. The KID also mentions that the fund is classified in category 3 for risk, indicating a certain level of volatility, but the complexity stems from the underlying investment strategy rather than the inherent market risk of the index components.",
        "esma_guidelines_reference": "ESMA35-36-1640 Supervisory briefing on Appropriateness and execution-only (April 2019) states in section 2.1, point 16: 'To assess whether such conditions are met, firms are likely to need processes (i) to distinguish between u201ccomplexu201d and u201cnon-complexu201d investment products; ...' and further in section 2.1, point 19, under Execution-only questions, it asks: 'What policies and processes has the firm set up to identify which of its investment products may be regarded as u201ccomplexu201d for the purposes of the appropriateness requirements?'. The provided KIID clearly indicates the use of derivatives (swaps) to achieve its investment objective, which aligns with the definition of complex instruments as per MiFID II and related ESMA guidance that highlights derivatives and synthetic replication as key complexity drivers due to associated risks like counterparty and collateral risk."
    }
}